Sadowski M - Search Results

1

In vivo micro magnetic resonance imaging signal changes in scrapie infected mice.

Sadowski M, Tang CY, Aguinaldo JG, Carp R, Meeker HC, Wisniewski T. Sadowski M, et al. Neurosci Lett. 2003 Jul 10;345(1):1-4. doi: 10.1016/s0304-3940(03)00319-7. Neurosci Lett. 2003. PMID: 12809974

2

Targeting prion amyloid deposits in vivo.

Sadowski M, Pankiewicz J, Scholtzova H, Tsai J, Li Y, Carp RI, Meeker HC, Gambetti P, Debnath M, Mathis CA, Shao L, Gan WB, Klunk WE, Wisniewski T. Sadowski M, et al. J Neuropathol Exp Neurol. 2004 Jul;63(7):775-84. doi: 10.1093/jnen/63.7.775. J Neuropathol Exp Neurol. 2004. PMID: 15290902

3

Clearance and prevention of prion infection in cell culture by anti-PrP antibodies.

Pankiewicz J, Prelli F, Sy MS, Kascsak RJ, Kascsak RB, Spinner DS, Carp RI, Meeker HC, Sadowski M, Wisniewski T. Pankiewicz J, et al. Among authors: sadowski m. Eur J Neurosci. 2006 May;23(10):2635-47. doi: 10.1111/j.1460-9568.2006.04805.x. Eur J Neurosci. 2006. PMID: 16817866 Free PMC article.

4

Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.

Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. Wadghiri YZ, et al. Among authors: sadowski m. Magn Reson Med. 2003 Aug;50(2):293-302. doi: 10.1002/mrm.10529. Magn Reson Med. 2003. PMID: 12876705 Free article.

5

Vaccines for conformational disorders.

Sadowski M, Wisniewski T. Sadowski M, et al. Expert Rev Vaccines. 2004 Jun;3(3):279-90. doi: 10.1586/14760584.3.3.279. Expert Rev Vaccines. 2004. PMID: 15176944 Free article. Review.

6

Disease modifying approaches for Alzheimer's pathology.

Sadowski M, Wisniewski T. Sadowski M, et al. Curr Pharm Des. 2007;13(19):1943-54. doi: 10.2174/138161207781039788. Curr Pharm Des. 2007. PMID: 17627527 Review.

7

Links between the pathology of Alzheimer's disease and vascular dementia.

Sadowski M, Pankiewicz J, Scholtzova H, Li YS, Quartermain D, Duff K, Wisniewski T. Sadowski M, et al. Neurochem Res. 2004 Jun;29(6):1257-66. doi: 10.1023/b:nere.0000023612.66691.e6. Neurochem Res. 2004. PMID: 15176482

8

Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.

Sadowski M, Pankiewicz J, Scholtzova H, Ji Y, Quartermain D, Jensen CH, Duff K, Nixon RA, Gruen RJ, Wisniewski T. Sadowski M, et al. J Neuropathol Exp Neurol. 2004 May;63(5):418-28. doi: 10.1093/jnen/63.5.418. J Neuropathol Exp Neurol. 2004. PMID: 15198121

9

A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, Mathews PM, Fryer JD, Holtzman DM, Sigurdsson EM, Wisniewski T. Sadowski M, et al. Am J Pathol. 2004 Sep;165(3):937-48. doi: 10.1016/s0002-9440(10)63355-x. Am J Pathol. 2004. PMID: 15331417 Free PMC article.

10

Therapeutics and prion disease: can immunisation or drugs be effective?

Sassoon J, Sadowski M, Wisniewski T, Brown DR. Sassoon J, et al. Among authors: sadowski m. Mini Rev Med Chem. 2005 Apr;5(4):361-6. doi: 10.2174/1389557053544065. Mini Rev Med Chem. 2005. PMID: 15853626 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters